An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study.
about
Exercise for cancer cachexia in adultsExercise for cancer cachexia in adultsNeutrophil-to-lymphocyte ratio for predicting palliative chemotherapy outcomes in advanced pancreatic cancer patientsExercise interventions for people undergoing multimodal cancer treatment that includes surgeryC-Reactive Protein Is an Important Biomarker for Prognosis Tumor Recurrence and Treatment Response in Adult Solid Tumors: A Systematic ReviewNonmuscle Tissues Contribution to Cancer CachexiaInflammation-based scores: a new method for patient-targeted strategies and improved perioperative outcome in cancer patientsClinical Calculator for Early Mortality in Metastatic Colorectal Cancer: An Analysis of Patients From 28 Clinical Trials in the Aide et Recherche en Cancérologie Digestive Database.Predictive value of the modified Glasgow Prognostic Score for the therapeutic effects of molecular-targeted drugs on advanced renal cell carcinoma.A novel blood tool of cancer prognosis in esophageal squamous cell carcinoma: the Fibrinogen/Albumin RatioPretreatment C-reactive protein to albumin ratio for predicting overall survival in advanced pancreatic cancer patientsBiliary drainage improves the predictive value of modified Glasgow Prognostic Scores in inoperable pancreatic cancer.Prognostic Value of Computed Tomography: Measured Parameters of Body Composition in Primary Operable Gastrointestinal CancersDiscovery of lung cancer biomarkers by profiling the plasma proteome with monoclonal antibody libraries.The modified glasgow prognostic score is an independent prognostic factor in patients with inoperable thoracic esophageal squamous cell carcinoma undergoing chemoradiotherapyThe relationships between body composition and the systemic inflammatory response in patients with primary operable colorectal cancer.The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma.Glasgow Prognostic Score (GPS) can be a useful indicator to determine prognosis of patients with colorectal carcinoma.Glasgow prognostic score in patients receiving chemotherapy for non-small-cell lung cancer in stages IIIb and IV.Serum C-reactive protein (CRP) as a simple and independent prognostic factor in extranodal natural killer/T-cell lymphoma, nasal typeElevated platelet count as predictor of recurrence in rectal cancer patients undergoing preoperative chemoradiotherapy followed by surgery.Procalcitonin improves the Glasgow Prognostic Score for outcome prediction in emergency patients with cancer: a cohort study.Simple and Objective Prediction of Survival in Patients with Lung Cancer: Staging the Host Systemic Inflammatory Response.Clinical utility of the Glasgow Prognostic Score in patients undergoing curative nephrectomy for renal clear cell cancer: basis of new prognostic scoring systems.Neutrophil count is associated with survival in localized prostate cancerModified Glasgow prognostic score is an independent prognostic factor in patients with cervical cancer undergoing chemoradiotherapyModified glasgow prognostic score predicting high conversion ratio in opioid switching from oral oxycodone to transdermal fentanyl in patients with cancer painPretreatment neutrophil-to-lymphocyte ratio predicts the prognosis in patients with metastatic prostate cancerIncreased neutrophil-to-lymphocyte ratio is associated with disease-specific mortality in patients with penile cancerA clinical decision support tool to predict survival in cancer patients beyond 120 days after palliative chemotherapyThe Relationship between Sarcopenia and Systemic Inflammatory Response for Cancer Cachexia in Small Cell Lung CancerSystemic Inflammatory Response and Elevated Tumour Markers Predict Worse Survival in Resectable Pancreatic Ductal AdenocarcinomaPrognostic Significance of Modified Advanced Lung Cancer Inflammation Index (ALI) in Patients with Small Cell Lung Cancer_ Comparison with Original ALI.Transaminase Activity Predicts Survival in Patients with Head and Neck CancerA derived neutrophil to lymphocyte ratio predicts survival in patients with cancer.Prognostic Value of the Modified Glasgow Prognostic Score in Patients Undergoing Radical Surgery for Hepatocellular CarcinomaThe prognostic influence of body mass index, resting energy expenditure and fasting blood glucose on postoperative patients with esophageal cancer.Prediagnostic nonsteroidal anti-inflammatory drug use and lung cancer survival in the VITAL study.Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinomaPrognostic significance of preoperative C-reactive protein: albumin ratio in patients with clear cell renal cell carcinoma.
P2860
Q24187827-E00D78AC-3CFD-4B9D-9842-89CBDA15C45FQ24197733-51BED09A-ABE6-44FA-9C6E-1E34C685E554Q24568136-06336B4F-6056-4D3F-9B07-125EF0CE38C9Q26471290-AB128C1D-AE94-4E22-A733-E9CA4FA46A38Q26771557-68619504-6BA5-4D5C-A3FE-D2EB162C8B9DQ26777562-A8387F9C-F15D-46A3-8E38-110718F939E6Q27009534-D3CB5FCA-9034-4E5E-B989-AE252A8C2975Q30313248-01DFF67A-0AF7-4773-84FE-B564D0E634C0Q33684941-5F699C76-D1DE-488F-A1AE-7C8B4DE8E07CQ33702344-D2F14CDA-A7E5-4C22-9C47-3676D6F28F80Q33774197-65819E52-C564-4849-BCFD-0B11888FECAAQ33828786-AC925D04-D7B9-4136-A92F-C6E78F3BFD8FQ33854959-369FB193-293D-4EB3-A0B7-25A72C54B2B1Q34030497-D610ACF7-731E-4F61-AA08-7D54528EB1C0Q34241072-5F79FEE0-FA78-4DCE-8B97-446F228CE64DQ34369105-B4DF5A4B-3E6C-446E-9A0F-E98E8C21FB68Q34572243-E8DBCBF2-1801-4D7B-9174-B3E989CD3DBCQ34621908-DB8F480E-3076-4B8D-A139-5CEADAB150AEQ34746166-B6ACF804-60C1-48E8-A427-3414114CB3EAQ34749502-925CB083-D438-414C-A038-F7AA63CF902AQ35110652-33BAEABE-75A0-4E74-9ECB-972D51016A34Q35226677-F7B3F07F-F50D-4E14-9345-655732EDF188Q35623609-9A255741-85E5-4535-821D-2E54125BA4D3Q35682006-E8521D28-AE1C-4966-BDE3-BD8BBB6257B0Q35751637-439B5596-A9DA-4287-8CEA-27A35CB9D797Q35851207-CD2B77A7-2463-49E6-8EF4-0F2322ACE194Q35870860-4A980D28-A3C0-4AF7-AD70-D7FFEAC357C0Q35925423-A35712B1-F7C1-4ECD-A7E4-F60FAE7E3C7DQ36069609-02DD2D23-9A67-4B75-8A2A-4830DA0FE2C4Q36093188-805A5E40-EA4D-44E7-AFB4-69C12ABF5629Q36107012-83AD1CC5-DA53-40BF-9D88-38CABC241E5BQ36134440-6D019A82-62D4-4BCD-A3FE-09003C8D4EB2Q36153929-DDFD2DC3-66E6-4321-9E60-F8E8560F526DQ36161469-39184F5C-4955-4863-AE39-BC985F91F999Q36166771-86E1C83B-13FE-4AD0-8B96-9A161C0728A3Q36194925-6FCC0F45-FFDD-432A-9993-6A2C6706319DQ36230716-6939B217-0C63-4918-BD3D-EEE18B62EB0DQ36242634-097B3080-E02D-432A-B2FD-95EA85C83151Q36299107-4E1EEBE8-2E75-4F60-BEB3-3BDB52DCD80AQ36464694-C2BC9B3D-F935-4033-B95B-6C31B8A347C7
P2860
An inflammation-based prognostic score (mGPS) predicts cancer survival independent of tumour site: a Glasgow Inflammation Outcome Study.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
An inflammation-based prognost ...... ow Inflammation Outcome Study.
@ast
An inflammation-based prognost ...... ow Inflammation Outcome Study.
@en
An inflammation-based prognostic score
@nl
type
label
An inflammation-based prognost ...... ow Inflammation Outcome Study.
@ast
An inflammation-based prognost ...... ow Inflammation Outcome Study.
@en
An inflammation-based prognostic score
@nl
prefLabel
An inflammation-based prognost ...... ow Inflammation Outcome Study.
@ast
An inflammation-based prognost ...... ow Inflammation Outcome Study.
@en
An inflammation-based prognostic score
@nl
P2093
P2860
P356
P1476
An inflammation-based prognost ...... gow Inflammation Outcome Study
@en
P2093
A K Foulis
D S J O'Reilly
M J Proctor
P G Horgan
S M Balmer
P2860
P2888
P304
P356
10.1038/SJ.BJC.6606087
P407
P577
2011-01-25T00:00:00Z
P5875
P6179
1003536381